HELIOS Kliniken

IMPULSE: The impact of gender on the presentation and management of aortic stenosis across Europe (2021) Steeds RP, Messika-Zeitoun D, Thambyrajah J, Serra A, Schulz E, Maly J, Aiello M, et al. Journal article Recommendations for the management of COVID-19 pandemic in long term care facilities Langzeitpflege in COVID-19-Zeiten: Leitfaden zur medizinischen Versorgung (2021) Gosch M, Heppner HJ, Singler K Journal article, Review article Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021 (2021) Ewig S, Kolditz M, Pletz M, Altiner A, Albrich W, Drömann D, Flick H, et al. Journal article, Review article MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening. (2021) Schellinger IN, Wagenhaeuser M, Chodisetti G, Mattern K, Dannert A, Petzold A, Jakubizka-Smorag J, et al. Journal article Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection (2021) Wagner KI, Mateyka LM, Jarosch S, Grass V, Weber S, Schober K, Hammel M, et al. Journal article, Original article Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer (2021) Schneeweiss A, Michel LL, Möbus V, Tesch H, Klare P, Hahnen E, Denkert C, et al. Journal article Erratum: AGO Recommendations for the Surgical Therapy of the Axilla after Neoadjuvant Chemotherapy: 2021 Update (Geburtshilfe Frauenheilkd (2021) 81:10 (1112-1120) DOI: 10.1055/a-1499-8431) (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Paluchowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Erratum Phase III post-neoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA (2021) Marme F, Hanusch C, Furlanetto J, Denkert C, Link T, Untch M, Blohmer JU, et al. Conference contribution Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Gruenwald V, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa) (2021) Eichler M, Pink D, Menge F, Jakob J, Hentschel L, Richter S, Hohenberger P, et al. Journal article